A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Conditions: Uterine Fibroids; Endometriosis Intervention: Drug: Relugolix Combination Tablet Sponsor: Myovant Sciences GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials